High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease
Coronavirus disease 2019 (COVID-19) vaccines are recommended for all patients with inflammatory bowel disease (IBD).1 Patients with IBD historically have had low vaccine uptake relative to the general population.2 However, a recent survey suggested a rate higher than that of the general population w...
Gespeichert in:
| Veröffentlicht in: | Clinical gastroenterology and hepatology 2022-07, Vol.20 (7), p.1606-1608.e2 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1608.e2 |
|---|---|
| container_issue | 7 |
| container_start_page | 1606 |
| container_title | Clinical gastroenterology and hepatology |
| container_volume | 20 |
| creator | Schell, Trevor L. Richard, Luke J. Tippins, Katharine Russ, Rachel K. Hayney, Mary S. Caldera, Freddy |
| description | Coronavirus disease 2019 (COVID-19) vaccines are recommended for all patients with inflammatory bowel disease (IBD).1 Patients with IBD historically have had low vaccine uptake relative to the general population.2 However, a recent survey suggested a rate higher than that of the general population with regard to COVID-19 vaccine intent among the IBD population. Their study was limited being that 96% of the patients surveyed identified as White, and 88% had attained a bachelor’s degree or higher level of education.3 Therefore, these findings may not be representative of the IBD population as a whole. Previous studies have indeed identified disparities in influenza vaccine uptake within the IBD population.4,5 |
| doi_str_mv | 10.1016/j.cgh.2021.12.013 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8654458</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1542356521013082</els_id><sourcerecordid>2609458937</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-de67adbb6d86dff2dfe591081dee40cf6fa347f9dbfbeed0c3c770ff8087a9d63</originalsourceid><addsrcrecordid>eNp9kUFPHCEYhknTplrbH9BLw7GXGYFhmJk0aaKrrZuY2EP10gNh4GOX7cywAqPx3xezq6kXT5DwvC9fvgehz5SUlFBxvCn1al0ywmhJWUlo9QYd0pqzomkof7u_V7WoD9CHGDeEsI53zXt0UPG2E6ylh-jPhVut8emc8HKC29kl1Q-AF1c3y7OCdvhGae0mwNfbpP4CPhn9tMK_VHIwpYjvXVrnnB3UOKrkwwM-9fcw4DMXQUX4iN5ZNUT4tD-P0PWP89-Li-Ly6udycXJZaF7TVBgQjTJ9L0wrjLXMWKg7SlpqADjRVlhV8cZ2prc9gCG60k1DrG1J26jOiOoIfd_1bud-BKPzbEENchvcqMKD9MrJly-TW8uVv5OtqDmv21zwdV8Q_O0MMcnRRQ3DoCbwc5RMkC5zXdVklO5QHXyMAezzN5TIRylyI7MU-ShFUiazlJz58v98z4knCxn4tgMgb-nOQZBR5w1rMC6ATtJ490r9P2Epnv8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2609458937</pqid></control><display><type>article</type><title>High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease</title><source>Elsevier ScienceDirect Journals</source><creator>Schell, Trevor L. ; Richard, Luke J. ; Tippins, Katharine ; Russ, Rachel K. ; Hayney, Mary S. ; Caldera, Freddy</creator><creatorcontrib>Schell, Trevor L. ; Richard, Luke J. ; Tippins, Katharine ; Russ, Rachel K. ; Hayney, Mary S. ; Caldera, Freddy</creatorcontrib><description>Coronavirus disease 2019 (COVID-19) vaccines are recommended for all patients with inflammatory bowel disease (IBD).1 Patients with IBD historically have had low vaccine uptake relative to the general population.2 However, a recent survey suggested a rate higher than that of the general population with regard to COVID-19 vaccine intent among the IBD population. Their study was limited being that 96% of the patients surveyed identified as White, and 88% had attained a bachelor’s degree or higher level of education.3 Therefore, these findings may not be representative of the IBD population as a whole. Previous studies have indeed identified disparities in influenza vaccine uptake within the IBD population.4,5</description><identifier>ISSN: 1542-3565</identifier><identifier>EISSN: 1542-7714</identifier><identifier>DOI: 10.1016/j.cgh.2021.12.013</identifier><identifier>PMID: 34896281</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Original</subject><ispartof>Clinical gastroenterology and hepatology, 2022-07, Vol.20 (7), p.1606-1608.e2</ispartof><rights>2022 AGA Institute</rights><rights>Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.</rights><rights>2022 by the AGA Institute. 2022 AGA Institute</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-de67adbb6d86dff2dfe591081dee40cf6fa347f9dbfbeed0c3c770ff8087a9d63</citedby><cites>FETCH-LOGICAL-c451t-de67adbb6d86dff2dfe591081dee40cf6fa347f9dbfbeed0c3c770ff8087a9d63</cites><orcidid>0000-0002-2058-4926</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.cgh.2021.12.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34896281$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schell, Trevor L.</creatorcontrib><creatorcontrib>Richard, Luke J.</creatorcontrib><creatorcontrib>Tippins, Katharine</creatorcontrib><creatorcontrib>Russ, Rachel K.</creatorcontrib><creatorcontrib>Hayney, Mary S.</creatorcontrib><creatorcontrib>Caldera, Freddy</creatorcontrib><title>High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease</title><title>Clinical gastroenterology and hepatology</title><addtitle>Clin Gastroenterol Hepatol</addtitle><description>Coronavirus disease 2019 (COVID-19) vaccines are recommended for all patients with inflammatory bowel disease (IBD).1 Patients with IBD historically have had low vaccine uptake relative to the general population.2 However, a recent survey suggested a rate higher than that of the general population with regard to COVID-19 vaccine intent among the IBD population. Their study was limited being that 96% of the patients surveyed identified as White, and 88% had attained a bachelor’s degree or higher level of education.3 Therefore, these findings may not be representative of the IBD population as a whole. Previous studies have indeed identified disparities in influenza vaccine uptake within the IBD population.4,5</description><subject>Original</subject><issn>1542-3565</issn><issn>1542-7714</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kUFPHCEYhknTplrbH9BLw7GXGYFhmJk0aaKrrZuY2EP10gNh4GOX7cywAqPx3xezq6kXT5DwvC9fvgehz5SUlFBxvCn1al0ywmhJWUlo9QYd0pqzomkof7u_V7WoD9CHGDeEsI53zXt0UPG2E6ylh-jPhVut8emc8HKC29kl1Q-AF1c3y7OCdvhGae0mwNfbpP4CPhn9tMK_VHIwpYjvXVrnnB3UOKrkwwM-9fcw4DMXQUX4iN5ZNUT4tD-P0PWP89-Li-Ly6udycXJZaF7TVBgQjTJ9L0wrjLXMWKg7SlpqADjRVlhV8cZ2prc9gCG60k1DrG1J26jOiOoIfd_1bud-BKPzbEENchvcqMKD9MrJly-TW8uVv5OtqDmv21zwdV8Q_O0MMcnRRQ3DoCbwc5RMkC5zXdVklO5QHXyMAezzN5TIRylyI7MU-ShFUiazlJz58v98z4knCxn4tgMgb-nOQZBR5w1rMC6ATtJ490r9P2Epnv8</recordid><startdate>20220701</startdate><enddate>20220701</enddate><creator>Schell, Trevor L.</creator><creator>Richard, Luke J.</creator><creator>Tippins, Katharine</creator><creator>Russ, Rachel K.</creator><creator>Hayney, Mary S.</creator><creator>Caldera, Freddy</creator><general>Elsevier Inc</general><general>by the AGA Institute</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2058-4926</orcidid></search><sort><creationdate>20220701</creationdate><title>High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease</title><author>Schell, Trevor L. ; Richard, Luke J. ; Tippins, Katharine ; Russ, Rachel K. ; Hayney, Mary S. ; Caldera, Freddy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-de67adbb6d86dff2dfe591081dee40cf6fa347f9dbfbeed0c3c770ff8087a9d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schell, Trevor L.</creatorcontrib><creatorcontrib>Richard, Luke J.</creatorcontrib><creatorcontrib>Tippins, Katharine</creatorcontrib><creatorcontrib>Russ, Rachel K.</creatorcontrib><creatorcontrib>Hayney, Mary S.</creatorcontrib><creatorcontrib>Caldera, Freddy</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schell, Trevor L.</au><au>Richard, Luke J.</au><au>Tippins, Katharine</au><au>Russ, Rachel K.</au><au>Hayney, Mary S.</au><au>Caldera, Freddy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease</atitle><jtitle>Clinical gastroenterology and hepatology</jtitle><addtitle>Clin Gastroenterol Hepatol</addtitle><date>2022-07-01</date><risdate>2022</risdate><volume>20</volume><issue>7</issue><spage>1606</spage><epage>1608.e2</epage><pages>1606-1608.e2</pages><issn>1542-3565</issn><eissn>1542-7714</eissn><abstract>Coronavirus disease 2019 (COVID-19) vaccines are recommended for all patients with inflammatory bowel disease (IBD).1 Patients with IBD historically have had low vaccine uptake relative to the general population.2 However, a recent survey suggested a rate higher than that of the general population with regard to COVID-19 vaccine intent among the IBD population. Their study was limited being that 96% of the patients surveyed identified as White, and 88% had attained a bachelor’s degree or higher level of education.3 Therefore, these findings may not be representative of the IBD population as a whole. Previous studies have indeed identified disparities in influenza vaccine uptake within the IBD population.4,5</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34896281</pmid><doi>10.1016/j.cgh.2021.12.013</doi><orcidid>https://orcid.org/0000-0002-2058-4926</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1542-3565 |
| ispartof | Clinical gastroenterology and hepatology, 2022-07, Vol.20 (7), p.1606-1608.e2 |
| issn | 1542-3565 1542-7714 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8654458 |
| source | Elsevier ScienceDirect Journals |
| subjects | Original |
| title | High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T06%3A23%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20But%20Inequitable%20COVID-19%20Vaccine%20Uptake%20Among%20Patients%20with%20Inflammatory%20Bowel%20Disease&rft.jtitle=Clinical%20gastroenterology%20and%20hepatology&rft.au=Schell,%20Trevor%20L.&rft.date=2022-07-01&rft.volume=20&rft.issue=7&rft.spage=1606&rft.epage=1608.e2&rft.pages=1606-1608.e2&rft.issn=1542-3565&rft.eissn=1542-7714&rft_id=info:doi/10.1016/j.cgh.2021.12.013&rft_dat=%3Cproquest_pubme%3E2609458937%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2609458937&rft_id=info:pmid/34896281&rft_els_id=S1542356521013082&rfr_iscdi=true |